Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. These conditions are often associated with trauma and taboo. The more intimate the condition, the greater the requirement to come closer to customers, understand their world and develop solutions that are sensitive to their special needs. We call this intimate healthcare.
Closeness to all customers makes this possible. We listen to better understand needs and respond by finding new ways to do things better together. We lead the way by bringing the best ideas first and fast to market in the form of medical devices and service solutions.
Deeply private and personal medical conditions are our focus. Our passion to make a real difference to people’s lives is what drives and unites us. Our culture supports high ambitions and releases the full potential of our own people to achieve them.
1957
Headcount14,000
HeadquartersHoltedam 1, 3050 Humlebaek – Denmark
Line item in (eur) | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | N/A | 14,926,000,000.00 | 15,249,000,000.00 | 15,458,000,000.00 | 15,841,000,000.00 | 16,188,000,000.00 | 35,170,000,000.00 | 35,185,000,000.00 | 34,956,000,000.00 | 35,221,000,000.00 | 35,302,000,000.00 | 35,087,000,000.00 |
Noncurrent Assets | N/A | 8,286,000,000.00 | 8,542,000,000.00 | 8,631,000,000.00 | 8,847,000,000.00 | 8,904,000,000.00 | 27,001,000,000.00 | 26,482,000,000.00 | 26,184,000,000.00 | 25,942,000,000.00 | 25,979,000,000.00 | 25,414,000,000.00 |
Property Plant And Equipment | N/A | 3,424,000,000.00 | 3,569,000,000.00 | 3,660,000,000.00 | 3,785,000,000.00 | 3,845,000,000.00 | 4,220,000,000.00 | 4,237,000,000.00 | 4,474,000,000.00 | 4,557,000,000.00 | 4,788,000,000.00 | 4,941,000,000.00 |
Other Noncurrent Receivables | N/A | 23,000,000.00 | 24,000,000.00 | 31,000,000.00 | 26,000,000.00 | 26,000,000.00 | 28,000,000.00 | 29,000,000.00 | 31,000,000.00 | 30,000,000.00 | 35,000,000.00 | 36,000,000.00 |
Deferred Tax Assets | N/A | 669,000,000.00 | 711,000,000.00 | 709,000,000.00 | 743,000,000.00 | 739,000,000.00 | 849,000,000.00 | 847,000,000.00 | 674,000,000.00 | 663,000,000.00 | 656,000,000.00 | 661,000,000.00 |
Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | 25,000,000.00 | 25,000,000.00 | 25,000,000.00 | 41,000,000.00 | 41,000,000.00 | 41,000,000.00 | 43,000,000.00 | 51,000,000.00 | 51,000,000.00 | 68,000,000.00 | 68,000,000.00 |
Current Assets | N/A | 6,640,000,000.00 | 6,707,000,000.00 | 6,827,000,000.00 | 6,994,000,000.00 | 7,284,000,000.00 | 8,169,000,000.00 | 8,703,000,000.00 | 8,772,000,000.00 | 9,279,000,000.00 | 9,323,000,000.00 | 9,673,000,000.00 |
Inventories | N/A | 2,231,000,000.00 | 2,289,000,000.00 | 2,378,000,000.00 | 2,428,000,000.00 | 2,497,000,000.00 | 2,870,000,000.00 | 3,022,000,000.00 | 3,187,000,000.00 | 3,397,000,000.00 | 3,512,000,000.00 | 3,557,000,000.00 |
Current Trade Receivables | N/A | 2,916,000,000.00 | 3,108,000,000.00 | 3,142,000,000.00 | 3,212,000,000.00 | 3,215,000,000.00 | 3,648,000,000.00 | 3,837,000,000.00 | 3,940,000,000.00 | 3,953,000,000.00 | 3,988,000,000.00 | 4,072,000,000.00 |
Current Prepayments | N/A | 172,000,000.00 | 180,000,000.00 | 165,000,000.00 | 172,000,000.00 | 181,000,000.00 | 241,000,000.00 | 214,000,000.00 | 293,000,000.00 | 399,000,000.00 | 395,000,000.00 | 368,000,000.00 |
Other Current Receivables | N/A | 384,000,000.00 | 194,000,000.00 | 205,000,000.00 | 226,000,000.00 | 240,000,000.00 | 321,000,000.00 | 414,000,000.00 | 383,000,000.00 | 318,000,000.00 | 394,000,000.00 | 341,000,000.00 |
Current Tax Assets Current | N/A | 245,000,000.00 | 261,000,000.00 | 262,000,000.00 | 282,000,000.00 | 287,000,000.00 | 352,000,000.00 | 362,000,000.00 | 336,000,000.00 | 331,000,000.00 | 390,000,000.00 | 480,000,000.00 |
Cash and cash equivalents | 323,000,000.00 | 435,000,000.00 | 418,000,000.00 | 447,000,000.00 | 448,000,000.00 | 642,000,000.00 | 517,000,000.00 | 634,000,000.00 | 414,000,000.00 | 671,000,000.00 | 628,000,000.00 | 855,000,000.00 |
Current Investments | N/A | 257,000,000.00 | 257,000,000.00 | 228,000,000.00 | 226,000,000.00 | 222,000,000.00 | 220,000,000.00 | 220,000,000.00 | 219,000,000.00 | 210,000,000.00 | 16,000,000.00 | 0.00 |
Equity And Liabilities | N/A | 14,926,000,000.00 | 15,249,000,000.00 | 15,458,000,000.00 | 15,841,000,000.00 | 16,188,000,000.00 | 35,170,000,000.00 | 35,185,000,000.00 | 34,956,000,000.00 | 35,221,000,000.00 | 35,302,000,000.00 | 35,087,000,000.00 |
Equity | 7,406,000,000.00 | 5,770,000,000.00 | 6,936,000,000.00 | 6,927,000,000.00 | 8,168,000,000.00 | 6,419,000,000.00 | 7,273,000,000.00 | 7,275,000,000.00 | 8,292,000,000.00 | 5,905,000,000.00 | 7,034,000,000.00 | 6,490,000,000.00 |
Issued Capital | N/A | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 | 216,000,000.00 |
Retained Earnings | N/A | 5,876,000,000.00 | 6,080,000,000.00 | 7,111,000,000.00 | 5,406,000,000.00 | 6,668,000,000.00 | 6,182,000,000.00 | 7,429,000,000.00 | 5,386,000,000.00 | 6,451,000,000.00 | 6,572,000,000.00 | 7,877,000,000.00 |
Noncurrent Liabilities | N/A | 1,374,000,000.00 | 1,491,000,000.00 | 1,415,000,000.00 | 1,359,000,000.00 | 1,292,000,000.00 | 3,086,000,000.00 | 19,275,000,000.00 | 19,328,000,000.00 | 18,834,000,000.00 | 18,835,000,000.00 | 18,759,000,000.00 |
Noncurrent Provisions For Employee Benefits | N/A | 193,000,000.00 | 161,000,000.00 | 165,000,000.00 | 181,000,000.00 | 159,000,000.00 | 141,000,000.00 | 98,000,000.00 | 115,000,000.00 | 118,000,000.00 | 111,000,000.00 | 123,000,000.00 |
Other Longterm Provisions | N/A | 71,000,000.00 | 226,000,000.00 | 176,000,000.00 | 56,000,000.00 | 27,000,000.00 | 179,000,000.00 | 73,000,000.00 | 258,000,000.00 | 199,000,000.00 | 198,000,000.00 | 123,000,000.00 |
Noncurrent Accruals And Noncurrent Deferred Income Including Noncurrent Contract Liabilities | N/A | N/A | N/A | 10,000,000.00 | 2,000,000.00 | 3,000,000.00 | 20,000,000.00 | 20,000,000.00 | 7,000,000.00 | 7,000,000.00 | 8,000,000.00 | 8,000,000.00 |
Other Noncurrent Payables | N/A | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 16,000,000.00 | 16,000,000.00 | 3,000,000.00 | 3,000,000.00 |
Deferred Tax Liabilities | N/A | 628,000,000.00 | 638,000,000.00 | 631,000,000.00 | 671,000,000.00 | 673,000,000.00 | 2,263,000,000.00 | 2,208,000,000.00 | 2,077,000,000.00 | 1,469,000,000.00 | 1,473,000,000.00 | 1,439,000,000.00 |
Noncurrent Portion Of Noncurrent Bonds Issued | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 16,367,000,000.00 | 16,359,000,000.00 | 16,360,000,000.00 | 16,387,000,000.00 | 16,385,000,000.00 |
Current Liabilities | N/A | 7,782,000,000.00 | 6,822,000,000.00 | 7,116,000,000.00 | 6,314,000,000.00 | 8,477,000,000.00 | 24,811,000,000.00 | 8,635,000,000.00 | 7,336,000,000.00 | 10,482,000,000.00 | 9,433,000,000.00 | 9,838,000,000.00 |
Current Provisions For Employee Benefits | N/A | 13,000,000.00 | 13,000,000.00 | 13,000,000.00 | 15,000,000.00 | 15,000,000.00 | 5,000,000.00 | 5,000,000.00 | 6,000,000.00 | 6,000,000.00 | 5,000,000.00 | 5,000,000.00 |
Other Shortterm Provisions | N/A | 153,000,000.00 | 159,000,000.00 | 157,000,000.00 | 150,000,000.00 | 145,000,000.00 | 676,000,000.00 | 650,000,000.00 | 347,000,000.00 | 260,000,000.00 | 236,000,000.00 | 206,000,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 563,000,000.00 | 572,000,000.00 | 531,000,000.00 | 1,036,000,000.00 | 597,000,000.00 | 755,000,000.00 | 826,000,000.00 | 1,242,000,000.00 | 964,000,000.00 | 1,136,000,000.00 | 1,070,000,000.00 |
Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | N/A | 2,000,000.00 | 8,000,000.00 | 6,000,000.00 | 4,000,000.00 | 7,000,000.00 | 2,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 |
Other Current Payables | N/A | 2,225,000,000.00 | 1,661,000,000.00 | 1,869,000,000.00 | 1,840,000,000.00 | 2,451,000,000.00 | 2,043,000,000.00 | 2,287,000,000.00 | 2,544,000,000.00 | 2,711,000,000.00 | 2,095,000,000.00 | 1,991,000,000.00 |
Current Tax Liabilities Current | N/A | 627,000,000.00 | 743,000,000.00 | 696,000,000.00 | 928,000,000.00 | 657,000,000.00 | 727,000,000.00 | 1,141,000,000.00 | 1,342,000,000.00 | 1,372,000,000.00 | 1,354,000,000.00 | 1,513,000,000.00 |
Line item in (eur) | 01.10.2020/ 01.01.2021 |
01.10.2020/ 01.04.2021 |
01.10.2020/ 01.07.2021 |
01.10.2020/ 01.10.2021 |
01.01.2021/ 01.04.2021 |
01.03.2021/ 01.07.2021 |
01.10.2021/ 01.01.2022 |
01.10.2021/ 01.04.2022 |
01.10.2021/ 01.07.2022 |
01.10.2021/ 01.10.2022 |
01.01.2022/ 01.04.2022 |
01.03.2022/ 01.07.2022 |
01.04.2022/ 01.07.2022 |
01.10.2022/ 01.01.2023 |
01.10.2022/ 01.04.2023 |
01.10.2022/ 01.07.2023 |
01.01.2023/ 01.04.2023 |
01.04.2023/ 01.07.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4,738,000,000.00 | 9,491,000,000.00 | 14,326,000,000.00 | 19,426,000,000.00 | 4,753,000,000.00 | 4,835,000,000.00 | 5,169,000,000.00 | 10,671,000,000.00 | 16,520,000,000.00 | 22,579,000,000.00 | 5,502,000,000.00 | 5,849,000,000.00 | 5,849,000,000.00 | 6,105,000,000.00 | 12,166,000,000.00 | 18,274,000,000.00 | 6,061,000,000.00 | 6,108,000,000.00 |
Other Income | 15,000,000.00 | 25,000,000.00 | 57,000,000.00 | 73,000,000.00 | 10,000,000.00 | 32,000,000.00 | 14,000,000.00 | 29,000,000.00 | 59,000,000.00 | 74,000,000.00 | 15,000,000.00 | 30,000,000.00 | 30,000,000.00 | 9,000,000.00 | 26,000,000.00 | 39,000,000.00 | 17,000,000.00 | 13,000,000.00 |
Profit Loss From Operating Activities | 1,536,000,000.00 | 2,913,000,000.00 | 4,505,000,000.00 | 6,155,000,000.00 | 1,377,000,000.00 | 1,592,000,000.00 | 1,615,000,000.00 | 2,920,000,000.00 | 4,661,000,000.00 | 6,439,000,000.00 | 1,305,000,000.00 | 1,741,000,000.00 | 1,741,000,000.00 | 1,761,000,000.00 | 3,412,000,000.00 | 5,126,000,000.00 | 1,651,000,000.00 | 1,714,000,000.00 |
Finance Income | 18,000,000.00 | 85,000,000.00 | 129,000,000.00 | 137,000,000.00 | 67,000,000.00 | 44,000,000.00 | 19,000,000.00 | 69,000,000.00 | 148,000,000.00 | 119,000,000.00 | 50,000,000.00 | 79,000,000.00 | 79,000,000.00 | 31,000,000.00 | 73,000,000.00 | 110,000,000.00 | 42,000,000.00 | 37,000,000.00 |
Finance Costs | 59,000,000.00 | 28,000,000.00 | 45,000,000.00 | 59,000,000.00 | -31,000,000.00 | 17,000,000.00 | 77,000,000.00 | 145,000,000.00 | 294,000,000.00 | 431,000,000.00 | 68,000,000.00 | 149,000,000.00 | 149,000,000.00 | 365,000,000.00 | 597,000,000.00 | 738,000,000.00 | 232,000,000.00 | 141,000,000.00 |
Profit Loss Before Tax | 1,495,000,000.00 | 2,970,000,000.00 | 4,589,000,000.00 | 6,233,000,000.00 | 1,475,000,000.00 | 1,619,000,000.00 | 1,557,000,000.00 | 2,844,000,000.00 | 4,515,000,000.00 | 6,127,000,000.00 | 1,287,000,000.00 | 1,671,000,000.00 | 1,671,000,000.00 | 1,427,000,000.00 | 2,888,000,000.00 | 4,498,000,000.00 | 1,461,000,000.00 | 1,610,000,000.00 |
Income Tax Expense Continuing Operations | 359,000,000.00 | 704,000,000.00 | 1,069,000,000.00 | 1,408,000,000.00 | 345,000,000.00 | 365,000,000.00 | 350,000,000.00 | 657,000,000.00 | 1,039,000,000.00 | 1,421,000,000.00 | 307,000,000.00 | 382,000,000.00 | 382,000,000.00 | 300,000,000.00 | 606,000,000.00 | 944,000,000.00 | 306,000,000.00 | 338,000,000.00 |
Profit (loss) | 1,136,000,000.00 | 2,266,000,000.00 | 3,520,000,000.00 | 4,825,000,000.00 | 1,130,000,000.00 | 1,254,000,000.00 | 1,207,000,000.00 | 2,187,000,000.00 | 3,476,000,000.00 | 4,706,000,000.00 | 980,000,000.00 | 1,289,000,000.00 | 1,289,000,000.00 | 1,127,000,000.00 | 2,282,000,000.00 | 3,554,000,000.00 | 1,155,000,000.00 | 1,272,000,000.00 |
Line item in (eur) | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit (loss) | N/A | 1,136,000,000.00 | 1,130,000,000.00 | 1,254,000,000.00 | 4,825,000,000.00 | 1,207,000,000.00 | 980,000,000.00 | 1,289,000,000.00 | 4,706,000,000.00 | 1,127,000,000.00 | 1,155,000,000.00 | 1,272,000,000.00 |
Other Adjustments For Noncash Items | N/A | -48,000,000.00 | 120,000,000.00 | 80,000,000.00 | -31,000,000.00 | -19,000,000.00 | 172,000,000.00 | 75,000,000.00 | 56,000,000.00 | -73,000,000.00 | -81,000,000.00 | -166,000,000.00 |
Interest Paid Classified As Operating Activities | N/A | 10,000,000.00 | 41,000,000.00 | 67,000,000.00 | 81,000,000.00 | 95,000,000.00 | 55,000,000.00 | 210,000,000.00 | 378,000,000.00 | 102,000,000.00 | 155,000,000.00 | 611,000,000.00 |
Interest Received Classified As Operating Activities | N/A | 14,000,000.00 | 38,000,000.00 | 51,000,000.00 | 31,000,000.00 | 3,000,000.00 | 3,000,000.00 | 8,000,000.00 | 16,000,000.00 | 21,000,000.00 | 12,000,000.00 | 29,000,000.00 |
Cash Flows From Used In Operating Activities | N/A | 1,212,000,000.00 | 1,959,000,000.00 | 3,336,000,000.00 | 5,290,000,000.00 | 1,131,000,000.00 | 1,381,000,000.00 | 2,959,000,000.00 | 5,099,000,000.00 | 487,000,000.00 | 1,176,000,000.00 | 2,345,000,000.00 |
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | 59,000,000.00 | 97,000,000.00 | 97,000,000.00 | N/A | 10,633,000,000.00 | 10,633,000,000.00 | 10,633,000,000.00 | N/A | 0.00 | 0.00 |
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 3,000,000.00 | 4,000,000.00 | 36,000,000.00 | 36,000,000.00 | 0.00 | 7,000,000.00 | 10,000,000.00 | 11,000,000.00 | N/A | 2,000,000.00 | 3,000,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 975,000,000.00 | 997,000,000.00 | 1,022,000,000.00 | 1,047,000,000.00 | 26,000,000.00 | 61,000,000.00 | 114,000,000.00 | 208,000,000.00 | 77,000,000.00 | 134,000,000.00 | 161,000,000.00 |
Cash Flows From Used In Investing Activities | N/A | -1,226,000,000.00 | -1,513,000,000.00 | -1,710,000,000.00 | -2,011,000,000.00 | -201,000,000.00 | -11,096,000,000.00 | -11,358,000,000.00 | -11,759,000,000.00 | -275,000,000.00 | -381,000,000.00 | -655,000,000.00 |
Payments To Acquire Or Redeem Entitys Shares | N/A | N/A | 61,000,000.00 | 342,000,000.00 | 500,000,000.00 | N/A | 373,000,000.00 | 500,000,000.00 | 500,000,000.00 | N/A | 0.00 | 0.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | N/A | 0.00 | N/A | N/A | N/A | 16,373,000,000.00 | N/A | N/A | N/A | N/A | N/A |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 49,000,000.00 | 99,000,000.00 | 147,000,000.00 | 202,000,000.00 | 49,000,000.00 | 107,000,000.00 | 168,000,000.00 | 239,000,000.00 | 66,000,000.00 | 119,000,000.00 | 180,000,000.00 |
Dividends Paid Classified As Financing Activities | N/A | 2,765,000,000.00 | 2,765,000,000.00 | 3,830,000,000.00 | 3,830,000,000.00 | 2,979,000,000.00 | 2,979,000,000.00 | 4,041,000,000.00 | 4,041,000,000.00 | 3,185,000,000.00 | 3,185,000,000.00 | 4,247,000,000.00 |
Cash Flows From Used In Financing Activities | N/A | 125,000,000.00 | -369,000,000.00 | -1,520,000,000.00 | -3,176,000,000.00 | -745,000,000.00 | 9,771,000,000.00 | 8,550,000,000.00 | 6,591,000,000.00 | 74,000,000.00 | -549,000,000.00 | -1,204,000,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 111,000,000.00 | 77,000,000.00 | 106,000,000.00 | 103,000,000.00 | 185,000,000.00 | 56,000,000.00 | 151,000,000.00 | -69,000,000.00 | 286,000,000.00 | 246,000,000.00 | 486,000,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 1,000,000.00 | 17,000,000.00 | 17,000,000.00 | 20,000,000.00 | 9,000,000.00 | 15,000,000.00 | 37,000,000.00 | 37,000,000.00 | -29,000,000.00 | -32,000,000.00 | -45,000,000.00 |
Cash and cash equivalents | 323,000,000.00 | 435,000,000.00 | 418,000,000.00 | 447,000,000.00 | 448,000,000.00 | 642,000,000.00 | 517,000,000.00 | 634,000,000.00 | 414,000,000.00 | 671,000,000.00 | 628,000,000.00 | 855,000,000.00 |
Please note that some sums might not add up.
DK0060448595
LEI529900NN7SOJ5QG82X67
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryOMX Copenhagen 20
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.